In otherwise healthy adults, which antibiotics are recommended for treating the listed bacterial pathogens?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Antibiotic Selection by Bacterial Pathogen

For otherwise healthy adults, antibiotic selection should be guided by the specific bacterial pathogen identified or suspected, with first-line agents chosen based on established efficacy and resistance patterns.

Gram-Positive Cocci

Staphylococcus aureus (Methicillin-Susceptible)

  • First-line: Nafcillin, oxacillin, or cefazolin 1
  • Oral alternatives: Dicloxacillin or cefalexin 1
  • Penicillin-allergic: Clindamycin 1

Staphylococcus aureus (MRSA)

  • First-line: Vancomycin 1
  • Alternatives: Linezolid, daptomycin, or ceftaroline 1
  • Oral options for uncomplicated infections: Sulfamethoxazole-trimethoprim, doxycycline, or clindamycin 1

Streptococcus species (including S. pneumoniae)

  • First-line: Benzylpenicillin (penicillin G) or phenoxymethylpenicillin (penicillin V) 1
  • For S. pneumoniae with decreased penicillin susceptibility: Amoxicillin remains effective 2
  • Penicillin-allergic: Clindamycin 1

Group A Streptococcus (Pharyngitis)

  • First-line: Penicillin 3
  • Penicillin-allergic: Erythromycin 3

Gram-Negative Bacilli

Pseudomonas aeruginosa

  • Effective agents: Piperacillin-tazobactam, ceftazidime, cefepime, aztreonam, or carbapenems 1
  • These agents provide reliable anti-pseudomonal coverage for serious infections

Aeromonas hydrophila

  • Combination therapy: Doxycycline plus ciprofloxacin OR ceftriaxone 1

Vibrio vulnificus

  • Combination therapy: Doxycycline plus ceftriaxone OR cefotaxime 1

Anaerobes

Clostridium species

  • Combination therapy: Clindamycin plus penicillin 1

Mixed anaerobic infections

  • Effective agents: Metronidazole or clindamycin 1
  • Broad-spectrum options: Piperacillin-tazobactam, ampicillin-sulbactam, or carbapenems 1

Atypical Pathogens

Mycoplasma pneumoniae

  • First-line: Macrolides (erythromycin, azithromycin) 4, 5
  • Alternatives: Doxycycline or fluoroquinolones (levofloxacin, moxifloxacin) 2, 4

Chlamydia pneumoniae

  • First-line: Macrolides 4, 5
  • Alternatives: Doxycycline or fluoroquinolones 4

Legionella pneumophila

  • First-line: Fluoroquinolones (levofloxacin or moxifloxacin) 2
  • Alternative: Macrolides 4, 6
  • Note: Fluoroquinolones are now widely recommended over macrolides for Legionella 2

Polymicrobial Infections

Animal Bites

  • Oral: Amoxicillin-clavulanic acid 1
  • Intravenous: Ampicillin-sulbactam or piperacillin-tazobactam 1
  • Alternatives: Second/third-generation cephalosporins (cefuroxime, ceftriaxone), carbapenems 1

Human Bites

  • First-line: Amoxicillin-clavulanic acid or ampicillin-sulbactam 1
  • Alternatives: Carbapenems or doxycycline 1

Necrotizing Fasciitis

  • Broad-spectrum combination: Vancomycin or linezolid PLUS piperacillin-tazobactam or a carbapenem 1
  • Alternative combination: Ceftriaxone plus metronidazole 1

Important Clinical Considerations

Resistance patterns: Cotrimoxazole and tetracyclines show increasing resistance in respiratory pathogens 6. Fluoroquinolone resistance in S. pneumoniae is not easily detected with routine laboratory methods 2.

Moxifloxacin vs. levofloxacin: While clinical outcomes are equivalent, moxifloxacin demonstrates superior bacteriological and pharmacological activity against S. pneumoniae compared to levofloxacin 500 mg/day 2.

Common pitfall: Avoid treating viral pharyngitis with antibiotics. Only 10% of adult pharyngitis cases are caused by Group A Streptococcus 3. Use Centor criteria to guide testing and treatment decisions.

De-escalation principle: Start with appropriate empiric coverage, then narrow therapy based on culture results and clinical response 7, 8. This approach reduces resistance development and adverse effects while maintaining efficacy.

References

2
Research

[Antibiotherapy for acute CAP in adults].

Medecine et maladies infectieuses, 2006

7
Research

Antibiotic therapy for severe bacterial infections.

Intensive care medicine, 2025

Related Questions

What is the first-line antibiotic for an adult with lower respiratory crepitations, fever, and sore throat?
Should a 1.1 cm ovarian follicle be followed up with repeat ultrasound?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
How should a 10-year-old boy with two episodes of diarrhea, mild abdominal pain, and no fever be managed?
In a pediatric patient using polymyxin B‑hydrocortisone (Neosporin) ear drops at a dose of three drops three times daily for seven days, how common are side effects such as systemic toxicity or tinnitus?
If 1 mg lorazepam (Ativan) is not improving insomnia due to anxiety, is it safe to increase the dose?
What is the appropriate management of an active gastrointestinal bleed?
Should a patient with HIV infection be treated for Mycobacterium avium‑intracellulare (MAI)?
How should a patient with a serum potassium of 5.2 mEq/L be managed, especially when taking amoxicillin‑clavulanate?
Can an elderly, deconditioned, cachectic male without HIV tolerate treatment for Mycobacterium avium‑intracellulare (MAI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.